Shanghai Pharmaceuticals Stock (OTC: SHPMF)

Latest news for Shanghai Pharmaceuticals (OTC:SHPMF) Stock

Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue. It is vertically integrated and provides healthcare services in research and development, manufacturing, distribution, and retail. As of 2023, medical distribution is the largest segment, accounting for 89.8% of total revenue. It also has coverage of 31 provinces and cities nationwide.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

AAWW

ABBV

ABEO

ACER

ACGBF

ACGBY

ACOR

ACRGF

ACRS

ADAP

ADBCF

ADPT

AGDXF

AGIO

AHKSY

AKBA

AKCA

ALDR

ALFVF

ALFVY

ALNA

ALTM

ALTPF

ALXEF

AMCR

AMGDF

AMRX

ANAB

ANDE

APAFF

APEN

APNHF

APNHY

AQST

ARCH

AREVF

ARGGY

ASGLY

ASMB

ASNA

ASRT

ATRA

AVGR

AVLIF

AWRE

AXAS

AXION VENTURES INC by Axion Ventures Inc.

AXNVF

BACHF

BACHY

BAFYY

BASFY

BBBY

BBVA

BBVXF

BCDA

BCEL

BEDU

BELFA

BFIN

BICEY

BIDU

BJCHF

BLCM

BLMN

BNFT

BNKHF

BORR

BOXS

BRKMY

BRVRF

BSET

BrightSphere Investment Group plc Ordinary Shares

BSIG

BVTEF

BXEFF

BZLFY

CADE

CALX

CAMP

CANL

New 52-Week Lows For Monday Morning

AAMAF

ABMD

ADXS

AERI

AGFS

AMVMF

ARZTY

ASCK

AVAV

BEAT

BELFB

BLIN

BMRN

BMYMP

BNDSY

BNKXF

BRSWQ

CARS

CBKC

CBPX

CDEV

CDTI

CDTX

CELZ

CENT

CENTA

CESDF

CICHY

CICOY

CINR

CISN

CKHUY

CLSK

CLVS

CLXT

CMCM

CMVLF

COMM

CORV

CSBR

CTRA

CVLT

CWAFF

CYCN

Changyou Limited American Depositary Share

CYOU

DDAIF

DGMLF

DMLRY

DNJR

DOYU

Stocks That Set New 52-Week Lows Friday Morning

SHANGHAI PHARMS HL H ORD by Shanghai Pharmaceuticals Holdings Co., Ltd.

Shanghai Pharmaceuticals Holding Co Ltd

Hasten Biopharma entered a $325 million agreement for greater China rights to a PCSK9 inhibitor from LIB Therapeutics. Meanwhile, Insilico Medicine out-licensed global rights to a small molecule inhibitor of USP1 for BRCA-mutated tumors to Exelixis.

Week In Review: Hasten Signs $325 Million Deal For China Rights To PCSK9 Cholesterol Therapy

Shanghai Pharmaceuticals Holding Co (HK:2607) has released an update. Shanghai Pharmaceuticals Holding Co., Ltd. has confirmed the composition of i...

Shanghai Pharma Announces New Board Structure

Shanghai Pharmaceuticals Holding Co (HK:2607) has released an update. Shanghai Pharmaceuticals Holding Co., Ltd. has announced the resignation of M...

Shanghai Pharma Announces Board Resignation

Shanghai Pharmaceuticals Holding Co (HK:2607) has released an update. Shanghai Pharmaceuticals Holding Co., Ltd. has nominated Mr. Zhang Wenxue as ...

Shanghai Pharma Nominates New Board Member

Shanghai Pharmaceuticals Holding Co (HK:2607) has released an update. Shanghai Pharmaceuticals Holding Co., Ltd. has announced a final cash dividen...

Shanghai Pharma Declares Year-End Cash Dividend

Shanghai Pharmaceuticals Holding Co (HK:2607) has released an update. Shanghai Pharmaceuticals Holding Co., Ltd. has announced its Annual General M...

Shanghai Pharma Announces Upcoming AGM

Shanghai Pharmaceuticals Holding Co (HK:2607) has released an update. Shanghai Pharmaceuticals Holding Co., Ltd. has announced their annual general...

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Shanghai Pharmaceuticals

News

Latest news for Shanghai Pharmaceuticals (OTC:SHPMF) Stock

Monday, August 05, 2019

Friday, August 02, 2019